IBM (IBM) to Acquire Octo
- Wall Street ends higher, notches weekly gains as Fed meeting looms
- Intel pares losses but sheds $9 billion in value on dire outlook, dividend concerns
- Analysts rush to cut Intel (INTC) price targets following weaker than expected Q1 guidance
- Lucid Group (LCID) doubles on Saudi rumors
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
IBM (NYSE: IBM) today announced an agreement to acquire Octo, a U.S.-based IT modernization and digital transformation services provider exclusively serving the U.S. federal government, including defense, health, and civilian agencies. IBM's acquisition of Octo establishes one of the largest digital transformation partners to the federal government. Upon the close of the acquisition, Octo's approximately 1,500 employees will join IBM Consulting's U.S. public and federal market organization.
Octo will be IBM's eighth acquisition of 2022. Since Arvind Krishna became CEO of IBM in April 2020, IBM has acquired more than 25 companies, bolstering its hybrid cloud and artificial intelligence (AI) capabilities. Today's news builds on prior IBM Consulting acquisitions, including Dialexa, Neudesic, and Taos.
Federal government agencies face significant challenges including technology skills shortages, rebuilding of U.S. domestic supply chains and more demand for citizen services. To address these complex challenges, agencies need an industry partner to help them navigate a scalable path to IT modernization with the power to leverage emerging technologies and applications, optimize costs and operational efficiencies, and improve security. The convergence of new hybrid cloud and AI technologies enables government to deliver rapid improvements and adapt to unprecedented challenges.
The acquisition of Reston, Va.-based Octo will complement IBM's existing strengths in IT modernization and digital transformation, enhancing its ability to support federal agencies with a flexible, modern approach to digital transformation and growing IBM Consulting's public and federal market organization to 4,200 highly-skilled employees. With a proven track record of enabling rapid IT modernization and seamless citizen engagement, Octo also brings deep federal mission experience, as well as certifications in the technologies most used across the federal government.
"Governments require agility and resiliency to meet the evolving needs of citizens directly and in real time," said John Granger, Senior Vice President of IBM Consulting. "The combination of Octo's highly qualified and respected team with IBM's consulting expertise, technical capabilities and strategic partner ecosystem will enable federal clients to transform faster and better serve citizens."
Building on a shared commitment to co-creation, oLabs, Octo's 14,000 square foot innovation center with in-house computing capability, expands IBM's ability to work collaboratively with federal agencies to rapidly prototype emerging technology solutions – enabling greater impact for federal agencies and the people they serve.
"Octo was founded on the belief that digital transformation could be delivered at scale to modernize the federal government's approach to today's most pressing challenges – from public healthcare to national security, to defense and intelligence," said Mehul Sanghani, Chief Executive Officer of Octo. "Today, we are excited to join forces with IBM to continue to deliver these digital transformation capabilities with greater reach and scale."
IBM's acquisition of Octo from Arlington Capital Partners is expected to close in the fourth quarter of this year and is subject to customary closing conditions and regulatory clearances. Financial details of the deal were not disclosed.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Akerna (KERN) will merge with Gryphon Digital Mining in an all-stock deal, to sell software business to POSaBIT Systems
- TXO Energy Partners, L.P. (TXO) IPO opens 10% higher
- Quince Therapeutics (QNCX) Completes the Sale of Legacy Protease Inhibitor Portfolio to Lighthouse Pharmaceuticals
Create E-mail Alert Related CategoriesCorporate News, Mergers and Acquisitions
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!